Holy Grail In Cancer Treatment? Moderna Erupts After Melanoma Vaccine Late-Stage Trial Success
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-08-19 21:40 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Business, Health, Law & Courts, Crime & Justice
--------------------------------------------------------------------
Snippet:
Moderna's shares soared as much as 83% in premarket trading in New York after its personalized cancer vaccine, developed in collaboration with Merck & Co., reduced the risk of melanoma returning in a large, late-stage trial. The result marks the first positive Phase 3 trial for a personalized cancer vaccine by any company.
--------------------------------------------------------------------